Table 1.
Estimated geometric group means of key pharmacokinetic parameters with 95% confidence intervals
| Analyte | Group | AUC∞ | Cmax | T1/2 | CLR |
|---|---|---|---|---|---|
| [h µg−1 ml−1] | [µg ml−1] | (h) | [ml h−1] | ||
| Tomopenem | Young men | 208 (184, 236) | 88.3 (78.4, 99.3) | 2.03 (1.87–2.22) | 3.52 (2.83, 4.38) |
| Elderly men | 254 (224, 287) | 88.5 (78.6, 99.6) | 2.41 (2.22–2.64) | 3.67 (2.95, 4.57) | |
| Elderly women | 301 (267, 340) | 110 (97.9, 124.1) | 2.27 (2.13–2.44) | 2.83 (2.28, 3.52) | |
| RO4957463 | Young men | 21.0 (18.0, 24.6) | 5.28 (4.35, 6.40) | 2.53 (2.19–3.04) | 9.84 (8.09, 11.973) |
| Elderly men | 29.3 (25.1, 34.3) | 4.83 (3.98, 5.86) | 4.22 (3.60–5.10) | 8.63 (7.10, 10.50) | |
| Elderly women | 35.8 (30.7, 41.9) | 6.26 (5.16, 7.59) | 3.89 (3.39–4.60) | 5.87 (4.83, 7,14) |